COCP · Cocrystal Pharma, Inc.

Summary

Cocrystal Pharma, Inc. filed an 8-K on February 19, 2026, including a press release as Exhibit 99.1 under Item 7.01, which is not deemed 'filed' for purposes of Section 18 of the Exchange Act. No specific event details or Item 7.01 content are disclosed in the provided document.

Key takeaways

• Form 8-K filed on 2026-02-19
• Item 7.01 referenced with Exhibit 99.1 Press Release
• Exhibit 99.1 not deemed 'filed' under Section 18
• Item 9.01 discloses exhibits including 99.1 and 104